throbber
Tetrahedron 58 (2002) 9903–9923
`
`Synthetic studies of himbacine, a potent antagonist of the
`muscarinic M2 subtype receptor 1. Stereoselective total synthesis
`and antagonistic activity of enantiomeric pairs of himbacine
`
`0S,60R)-diepihimbacine, 4-epihimbacine, and novel
`and (2
`himbacine congeners
`
`Masanori Takadoi,a,* Tadashi Katoh,b Akihiro Ishiwatab,† and Shiro Terashimab
`
`aDiscovery Research Laboratories, Kyorin Pharmaceutical Company Ltd, 2399-1 Nogi, Nogi-machi, Tochigi 329-0114, Japan
`bSagami Chemical Research Center, 2743-1 Hayakawa, Ayase, Kanagawa 252-1193, Japan
`
`Received 25 September 2002; accepted 21 October 2002
`
`Abstract—Total synthesis of an enantiomeric pair of himbacine 1 and ent-1 was achieved in a highly stereoselective manner by employing
`an intermolecular Diels – Alder reaction of tetrahydroisobenzofuran 8 with chiral furan-2(5H)-one (S)-9 and (R)-9, respectively, as a key step.
`0
`0
`R)-diepihimbacine 24 and ent-24, 4-epihimbacine 4-epi-1, and novel himbacine congeners bearing the same
`S,6
`An enantiomeric pair of (2
`tricyclic moiety as that of 1 were also successfully prepared by utilizing the key synthetic intermediates for 1, establishing the convergency
`and flexibility of the explored synthetic route. All of the synthesized compounds used were subjected to muscarinic M2 subtype receptor
`binding affinity assay, disclosing novel aspects of the structure – activity relationships for 1. q 2002 Elsevier Science Ltd. All rights reserved.
`
`1. Introduction
`
`Himbacine 1,
`isolated from the bark of Galbulimima
`baccata,
`is a potent antagonist of the muscarinic M2
`subtype receptor.2 This alkaloid bears a characteristic
`structural
`feature in which the perhydronaphtho[2,3-
`c]furan ring system consisting of cis-fused g-lactone and
`trans-fused decaline moieties is connected with trans-
`disubstituted piperidine via an (E)-double bond (Fig. 1).
`
`is well known that senile dementia associated with
`It
`Alzheimer’s disease is directly correlated with diminished
`levels of synaptic acetylcholine (ACh) in the cortical and
`hippocampal areas of the brain,3 and current forms of
`therapy address this issue, relying on the cholinergic
`hypothesis4 of memory dysfunction. Such therapies com-
`prise the following four approaches to enhance synaptic
`ACh levels, namely, use of an ACh esterase inhibitor,5 a
`choline acetyl transferase (ChAT) synthesis enhancer,6 a
`choline re-uptake enhancer,7 and a muscarinic receptor
`agent.8 It has been reported that enhancement of synaptic
`ACh levels can be achieved by antagonizing presynaptic
`
`Keywords: alkaloids; Diels– Alder reactions; natural products; asymmetric
`synthesis.
`
`* Corresponding author. Tel.: þ81-280-56-2201; fax: þ81-280-57-1293;
`
`e-mail: masanori.takadoi@mb2.kyorin-pharm.co.jp
`† Present address: RIKEN (The Institute of Physical and Chemical
`Research), 2-1 Hirosawa, Wako, Saitama 351-0198, Japan.
`
`Figure 1. Structure of natural himbacine 1.
`
`muscarinic M2 receptors which regulate ACh release, the
`latter which acts as an autoreceptor.9 Under
`these
`circumstances, the therapeutic agent requires the high M2/
`M1 selectivity because of the post-synaptic localization of
`the M1 receptor. Himbacine 1 was reported to be a potent
`antagonist of the muscarinic M2 subtype receptor with 10 –
`20-fold selectivity toward the M1 subtype. Therefore, much
`attention has been focused on 1 by medicinal and synthetic
`organic compound synthesis communities.10 Two total
`syntheses of 1 have hitherto been achieved by Hart –
`Kozikowski11 and Chackalamannil12 by employing intra-
`molecular Diels – Alder reaction as their key steps.
`
`In order to disclose novel aspects of the structure – activity
`relationships of 1, and moreover, to explore the promising
`congeners of 1 which may show more improved M2 subtype
`selectivity, an efficient synthetic route to 1 was sought
`
`0040–4020/02/$ - see front matter q 2002 Elsevier Science Ltd. All rights reserved.
`PII: S 0 0 4 0 - 4 0 2 0 ( 0 2 ) 0 1 3 5 8 - 3
`
`Liquidia's Exhibit 1033
`IPR2020-00770
`Page 1
`
`

`

`9904
`
`M. Takadoi et al. / Tetrahedron 58 (2002) 9903–9923
`
`Scheme 1. Novel synthetic design of himbacine 1 featuring intermolecular Diels – Alder reaction.
`
`which would be more convergent and flexible than those
`that had been previously reported.11,12 We wish to report
`here the novel total synthesis of an enantiomeric pair of
`himbacine 1 and ent-1 accomplished by a method featuring
`a highly stereoselective intermolecular Diels – Alder
`reaction as a key step. This paper is also concerned with
`0
`0
`S,6
`R)-diepihim-
`the synthesis of an enantiomeric pair of (2
`bacine 24 and ent-24, 4-epihimbacine 4-epi-1, and novel
`congeners of 1 prepared by employing the synthetic
`intermediates of 1 along with their M2 antagonistic
`activity.1 The latter studies were carried out in order to
`gain a more thorough understanding of the convergency and
`flexibility of the explored synthetic route and to disclose
`novel aspects of the structure – activity relationships of these
`molecules.
`
`2. Results and discussion
`
`2.1. Synthetic strategy
`
`Our synthetic strategy as regards 1 is outlined in Scheme 1.
`The key step of our synthesis was a highly stereoselective
`intermolecular Diels – Alder reaction between tetrahydro-
`isobenzofuran 8 and chiral furan-2(5H)-one (S)-9. Thus,
`the cycloadduct 7 was
`exo-selective construction of
`envisioned, based on a previously reported result of the
`reaction of 8 with maleic anhydride.13 It was expected that
`the four chiral centers of 7 could be introduced in a highly
`stereoselective manner due to the (S)-chirality of the methyl
`group at the C-5 position of (S)-9. All of the chiral centers of
`tricyclic alcohol 4a bear the natural absolute configuration
`of 1, and 4a was readily derived from 7 by sequential
`hydrogenation to saturated tetracyclic compound 6 from a
`convex face, ring opening of 6, followed by double bond
`isomerization to unsaturated alcohol 5, and hydrogenation.
`Introduction of an arylsulfonylmethyl group into 4 gave
`tricyclic sulfone 2, which was connected to the bottom half
`of 1, the piperidinaldehyde 3, according to Hart’s pro-
`cedure11 featuring the Julia – Lythgoe olefination protocol,
`followed by subsequent deprotection and N-methylation of
`the piperidine moiety.
`It
`is generally accepted that
`
`intermolecular Diels – Alder reactions are more convergent
`and flexible than the corresponding intramolecular reac-
`tions, especially in the synthesis of complex natural
`products. Therefore, our approach was anticipated to be
`not only more advantageous for the total synthesis of 1
`itself, but also more useful for the exploration of novel
`congeners of 1 by changing the starting tetrahydroiso-
`benzofuran derivatives, the chiral furan-2(5H)-one deriva-
`tives, and/or the chiral piperidine units. Actually,
`the
`usefulness of the explored synthetic route was exemplified
`by successful syntheses of enantiomeric ent-1 and some
`novel congeners of 1. These studies were accomplished by
`employing (R)-9 in place of (S)-9 and by constructing novel
`structural features from the synthetic intermediates of 1.
`
`2.2. Synthesis of natural himbacine 1
`
`tetrahydroisobenzofuran 814 and
`The starting materials,
`furan-2(5H)-one (S)-9,15 were synthesized in large quan-
`tities according to the reported procedure with some
`modifications. With 8 and (S)-9 in hand, the intermolecular
`Diels – Alder reaction could then be examined (Scheme 2).
`
`As shown in Table 1, heating of a mixture of 8 and (S)-9 in
`the absence (entry 1) or the presence (entries 2 – 4) of Lewis
`acid16,17 failed to afford 7. The same unsuccessful results
`
`Scheme 2. Intermolecular Diels– Alder reaction of tetrahydroisobenzo-
`furan 8 with (S)-furan-2(5H)-one (S)-9. (a) see Table 1; (b) H2, 10% Pd – C,
`EtOH, rt, 12 h, 96%.
`
`Liquidia's Exhibit 1033
`IPR2020-00770
`Page 2
`
`

`

`M. Takadoi et al. / Tetrahedron 58 (2002) 9903–9923
`
`9905
`
`Table 1. Intermolecular Diels– Alder reaction of tetrahydroisobenzofuran 8
`with furan-2(5H)-one (S)-9
`
`Entrya
`
`Catalyst
`(equiv.)
`
`Solvent
`
`Conditions
`
`Result
`(yield of 7, %)b
`
`1
`2
`3
`4
`5
`6
`7
`8
`9
`10
`
`1508C, 65 h
`Decomposition
`None
`None
`rt – 408C, 19 h Decomposition
`Toluene
`SiO2 – Et2AlCl
`rt, 9 h
`Decomposition
`Toluene
`SiO2 – TiCl4
`rt, 48 h
`No reaction
`Toluene
`Florisil
`rt, 48 h
`No reaction
`CH2Cl2
`ZnCl2 (2.0)
`16 (20)c
`(Ph3P)3RhCl (0.1) CF3CH2OH rt, 168 h
`59 (88)c
`rt, 120 h
`ZnI2 (0.5)
`CH2Cl2
`4 M LiNTf2
`Et2O
`rt, 48 h
`No reaction
`Benzene
`rt, 24 h
`Decomposition
`1 M LiBF4
`Et2O
`rt, 168 h
`58
`5 M LiClO4
`
`a Tetrahydroisobenzofuran 8 was allowed to react with furan-2(5H)-one
`(S)-9 (1– 1.5 equiv.).
`b The cycloadduct 7 was obtained as the sole product. No other reaction
`products were detected by 1H NMR analysis of the crude reaction
`mixture.
`c Corrected for the recovery of (S)-9.
`
`19
`
`18 and LiBF4
`were obtained by the reactions using LiNTf2
`(entries 8, 9). On the other hand, upon treatment with
`Wilkinson’s catalyst20 (entry 6), ZnI2 (entry 7), or 5 M
`LiClO4 – Et2O21 (entry 10), the cycloaddition reaction took
`place successfully, giving rise to cycloadduct 7. The
`reaction under Livinghouse’s condition (entry 6) gave 7
`with poor reproducibility. In the case of entry 7,
`the
`isolation of 7 was found to be troublesome due to the
`recovery of unreacted (S)-9. Among these conditions
`examined, use of 5 M LiClO4 – Et2O afforded the best
`results, producing 7 as the sole product in a 58% yield. As
`expected,
`it appeared that
`this Diels – Alder
`reaction
`proceeded in a highly exo-selective manner, affording 7 as
`the sole product. Exclusive formation of 7 was determined
`by the 1H NMR analysis of the crude reaction product. To
`the best of our knowledge, this is the first example of a
`Diels – Alder reaction of furan and furan-2(5H)-one deriva-
`tive.22 Since the structural determination of 7 by the spectral
`data proved difficult, and because 7 was also found to be
`fairly unstable, 7 was directly subjected to the next
`hydrogenation. Thus, hydrogenation of 7 under convention-
`al conditions occurred from the sterically less hindered
`convex face to give the hydrogenated compound 6 as the
`sole product in a 96% yield. The stereochemistry of 6
`
`included a cis – anti – cis ring system, and was confirmed by
`single-crystal X-ray diffraction analysis, as shown in
`Scheme 2.
`
`Next, our synthetic efforts were focused on converting the
`stereochemistries of 6 to those of 1, a cis – trans ring system
`(Scheme 3). Toward this end, we first examined a ring-
`opening reaction of the 7-oxabicyclo[2.2.1]heptane system
`in 6. After conducting the experiments, it was found that this
`reaction proceeded under basic conditions,23 giving rise to
`hydroxyenone 10 in a 92% yield. Treatment of 10 with 1,8-
`diazabicyclo[5.4.0]undec-7-ene efficiently underwent
`double-bond isomerization to afford deconjugated alcohol
`5 as the sole product in an 83% yield. This highly selective
`formation of 5 may be explained by thermodynamic control.
`In order to obtain saturated alcohol 4a bearing the desired
`cis – trans ring system, catalytic hydrogenation of 5 was next
`examined using the various catalytic systems shown in
`Table 2.
`
`Among the catalytic systems tested, hydrogenation of 5 in
`the presence of PtO2 was found to produce the saturated
`alcohol 4a as the sole product in a 96% yield (entry 4). On
`the other hand, employing other catalytic systems for this
`hydrogenation regularly gave a mixture of 4a and its isomer
`4b (C-3a, 9a position,
`the himbacine numbering). The
`structures of 4a and 4b were unambiguously determined by
`single-crystal X-ray diffraction analyses. The ratio of 4a to
`4b definitely depended on the metal species of the catalytic
`systems. Formation of 4b may be explained by the double-
`bond shift from C-8a, 9 to the C-3a, 9a position, followed by
`hydrogenation from the sterically less hindered direction
`opposite of the C-3 methyl group. However, the reason
`remains unclear why such an abnormal hydrogenation took
`place by catalytic systems not employing PtO2. Thus, the
`stereoselective
`construction
`of
`the
`dodecahydro-
`naphtho[2,3-c]furan ring system involved in 1 was readily
`accomplished in four steps from exo-cycloadduct 7,
`produced by the intermolecular Diels – Alder reaction.
`
`Prior to oxidation of the secondary hydroxy group at the C-4
`position of 4a, the lactone moiety was protected in a form of
`acetal by sequential reduction and acetalization, yielding
`a-methyl acetal 11, the thermodynamically more stable
`compound, in a 74% yield from 4a as almost the sole
`product (Scheme 4). The hydroxy group at the C-4 position
`of 11 was oxidized using the tetrapropylammonium
`perruthenate(VII)-4-methylmorpholine N-oxide (TPAP-
`NMO) system,24 producing ketone 12 in a 95% yield.
`Methylenation of 12 by Wittig reaction provided exo-
`methylene compound 13 in an 86% yield. Sequential
`
`Table 2. Catalytic hydrogenation of deconjugated alcohol 5
`
`Entrya
`
`Catalystb
`
`Ratio of 4a/4b (yield, %)c
`
`1
`2
`3
`4
`
`Rh– Al2O3
`10% Pd– C
`Raney Ni
`PtO2
`
`1:1 (92)
`5:1 (65)
`10:1 (76)
`1:0 (96)
`
`Scheme 3. Stereoselective construction of the tricyclic part 4a of 1.
`(a) LiN(TMS)2, THF, 278 to 2408C, 4 h, 92%; (b) DBU, toluene, 1008C,
`5 h, 83%; (c) see Table 2.
`
`a Hydrogenation was carried out at rt in EtOH.
`b Amount of the catalyst corresponding to the 10% weight of 5 was used.
`c The ratio of 4a – 4b was determined by the 1H NMR spectrum of the crude
`reduction product.
`
`Liquidia's Exhibit 1033
`IPR2020-00770
`Page 3
`
`

`

`9906
`
`M. Takadoi et al. / Tetrahedron 58 (2002) 9903–9923
`
`Scheme 4. Synthesis of the sulfone 2, the key intermediate of 1. (a) (i)
`DIBAL-H, Et2O, 2788C, 1 h, (ii) BF3·Et2O, MeOH, CH2Cl2, 260 – rt, 12 h,
`74% (two steps); (b) TPAP, 4-methylmorpholine N-oxide, MS 4 A˚ ,
`CH2Cl2, rt, 1.5 h, 95%; (c) Ph3PCH3I, NaN(TMS)2, Et2O, 08C to rt, 2 h,
`86%; (d) (i) BH3·THF, THF, 2788C to rt, 3 h, (ii) 30% H2O2, 10% NaOH,
`08C, 0.5 h, 14a:14b¼73:8%; (e) methanesulfonyl chloride, 4-(dimethyl-
`amino)pyridine, Et3N, CH2Cl2, 08C to rt, 3 h, 100%; (f) thiophenol, tBuOK,
`DMSO, rt, 3 h, 100%; (g) mCPBA, NaHCO3, CH2Cl2, rt, 2 h, 82%.
`
`hydroboration and oxidation gave rise to 4b-carbinol 14a in
`a 73% yield along with the undesired C-4 epimer 14b in an
`8% yield. When the hydroboration was carried out at 08C
`instead of at 2788C, the ratio of 14a to 14b was reduced to
`5:1. The structure of 14a bearing all of the desired chiral
`centers in the tricyclic part of 1, was rigorously confirmed,
`as shown by single-crystal X-ray diffraction analysis.
`Stereoselective formation of 14a may reflect
`increased
`steric hindrance of the b-face of 13.
`
`With 14a in hand, transformation of 14a into the known
`sulfone 211 was next examined. It was accomplished in an
`82% combined yield by a three-step sequence involving O-
`mesylation of the hydroxy group of 14a, replacement of the
`O-mesyl group in 15 with a phenylsulfide group, and
`oxidation of the resulting sulfide 16. Spectral and physical
`data of 2 were identical to those that have previously been
`reported.11
`
`The remaining task for the total synthesis was conversion of
`2 to 1 according to the Hart – Kozikowski procedure11
`(Scheme 5). Thus, the coupling reaction25,26 of 2 with
`aldehyde 3, prepared according to the reported procedure,27
`and a subsequent elimination reaction of the intermediary b-
`hydroxy sulfone almost exclusively provided olefin 17
`possessing (E)-stereochemistry in a 66% yield. Sequential
`oxidation of the acetal moiety in 17 and deprotection of the
`N-Boc group in 18 afforded the piperidine 19. Finally,
`reductive N-methylation of 19 furnished natural himbacine
`1 in a high yield over a three-step sequence. Physical and
`spectral properties of the synthetic sample of 1 were found
`to be identical to those previously reported.11b As described
`above, our efforts culminated in the successful development
`of a novel synthetic route to 1 in which the intermolecular
`Diels – Alder reaction of 8 with (S)-9 is employed as the key
`stereoselective reaction.
`
`Scheme 5. Completion of the total synthesis of natural himbacine 1.
`(a) nBuLi, 2788C, 1 h, 100% conversion (a mixture of the diastereomers);
`(b) 5% Na – Hg, Na2HPO4, MeOH, rt, 2.5 h, 66%; (c) Jones reagent,
`acetone, rt, 0.5 h, 100%; (d) trifluoroacetic acid, CH2Cl2, rt, 1.5 h, 100%;
`(e) 37% HCHO aq., NaBH3CN, CH3CN, rt, 0.5 h, 91%.
`
`2.3. Synthesis of unnatural ent-himbacine ent-1
`
`To clarify the relationship between the absolute configur-
`ation of 1 and muscarinic M2 subtype antagonistic activity,
`as well as to explore the convergency and flexibility of the
`developed synthetic route to 1, we next planned to
`synthesize the enantiomer of 1, unnatural ent-himbacine
`ent-1, by using (R)-915 instead of (S)-9 as a starting material.
`Synthesis of (R)-9 was accomplished starting with (R)-
`methyl lactate. According to the synthetic scheme to 1
`detailed above, we succeeded in obtaining ent-1 from (R)-9,
`disclosing prominent aspects of the explored synthetic
`route. Spectral data of ent-1 were superimposable on those
`of 1. To avoid confusion, the compounds carrying natural
`configurations are the only compounds depicted in Scheme
`2 – 5.
`
`2.4. Synthesis of an enantiomeric pair of (2
`diepihimbacine
`
`0S,6
`
`0R)-
`
`In order to elucidate the structure – activity relationships
`between the absolute configuration of the tricyclic moiety
`on 1 and the piperidine moiety, we next planned to
`0
`0
`S,6
`R)-diepihimbacine
`synthesize an enantiomeric pair of (2
`24 and ent-24. It was expected that the synthesis of 24 could
`be accomplished by the use of our explored synthetic route,
`employing the sulfone 2 with a natural absolute configur-
`ation and the chiral piperidinaldehyde ent-3 possessing an
`unnatural absolute configuration.
`
`Thus, the Julia – Lythgoe coupling reaction of 2 and ent-3
`was examined to produce 24 (Scheme 6). However, in
`contrast to the cases for the synthesis of 1 and ent-1, the
`starting material 2 was fully recovered when the reaction
`was quenched by adding water. It seems likely that the retro-
`aldol
`type of reaction might have occurred when the
`materials were immersed in excess water, probably due to
`the decreased stability of the in situ formed lithium aldolate
`or an aldol-type product under protic conditions. After much
`
`Liquidia's Exhibit 1033
`IPR2020-00770
`Page 4
`
`

`

`M. Takadoi et al. / Tetrahedron 58 (2002) 9903–9923
`
`9907
`
`Table 3. In vitro binding activity of 1, ent-1, 24, ent-24, and 4-epi-1
`
`Entry
`
`Compound
`
`2log Ki
`
`M1 (cortex)
`
`M2 (brainstem)
`
`1
`2
`3
`4
`5
`6
`
`1
`1a
`ent-1
`24
`ent-24
`4-epi-1
`
`7.1
`7.2
`5.9
`6.5
`6.5
`6.1
`
`a Authentic sample of 1.28
`
`7.9
`7.9
`6.3
`6.7
`6.7
`5.7
`
`against the muscarinic M1 and M2 subtype receptors were
`performed. Results of these assays are shown in Table 3. In
`contrast to 1, all of the tested compounds ent-1, 24, ent-24,
`and 4-epi-1 were found to show very weak comparable
`binding affinity against the muscarinic M1 and M2 subtype
`receptors. These results clearly indicated that the stereo-
`chemistry of both the tricyclic and the piperidine moieties of
`1 play crucial roles in its strong muscarinic M2 antagonistic
`activity.
`
`2.7. Synthesis of some novel congeners of 1
`
`With completion of the total synthesis of enantiomeric pairs
`0
`0
`of natural himbacine 1 and ent-1, (2
`S,6
`R)-diepihimbacine
`24 and ent-24, and 4-epihimbacine 4-epi-1, we next
`examined the synthesis of some novel congeners of 1.
`These studies were performed in order to further examine
`the convergency and flexibility of the explored synthetic
`scheme, and moreover, to disclose novel aspects of the
`structure – activity relationships. Studies of the synthesis and
`muscarinic M2 subtype antagonistic activity of himbacine
`congeners have thus far been reported by Kozikowski et al.10
`and Chackalamannil et al.12c Our novel synthesis and
`activity evaluation of 1, ent-1, 24, ent-24, and 4-epi-1
`disclosed that the absolute configuration plays a pivotal role
`in muscarinic M2 subtype antagonistic activity. Therefore, it
`appeared that novel congeners of himbacine should be
`synthesized in the natural configuration. Taking into
`account these points, we designed some novel congeners
`of 1, shown in Fig. 2. It was anticipated that the chiral
`piperidine ring of 1 could be replaced with various
`substituted heterocycles such as pyridine,
`imidazole,
`morpholine, pyrrolidine, and piperidine derivative. More-
`in 1 was expected to be
`the (E)-olefin present
`over,
`substituted by its bioisosteres such as ether, ester,
`carbamate, and amide bond species. Based on the above
`considerations, the compounds, 26, 28, 30, 32, 35, 37, 39,
`
`Figure 2. Novel himbacine congeners designed as synthetic targets.
`
`0
`0
`R)-diepihimbacine 24. (a) nBuLi, DME,
`Scheme 6. Synthesis of (2
`S,6
`278 to 2208C, 4 h; (b) (i) benzoyl chloride, 2208C to rt,1 h, (ii)
`3-(dimethylamino)propylamine, rt, 1 h; (c) 5% Na – Hg, Na2HPO4, MeOH,
`rt, 1 h, 33% (four steps) (recovery of 2: 51%); (d) Jones reagent, acetone, rt,
`2 h, 68%; (e) trifluoroacetic acid, CH2Cl2, rt, 0.5 h, 91%; (f) 37% HCHO
`aq., NaBH3CN, CH3CN, rt, 3 h, 73%.
`
`experimentation, it was finally found that quenching the
`reaction of 2 and ent-3 by the addition of excess benzoyl
`chloride successfully gave the desired benzoate 20 as a
`diastereomeric mixture after removal of the excess benzoyl
`chloride with 3-(dimethylamino)propylamine. Without
`separation, the reaction mixture was directly subjected to
`reductive elimination, giving rise to (E)-olefin 21 in a 33%
`yield from 2, along with a 51% recovery of 2. In this case as
`well, formation of the (Z)-olefin was not observed by 1H
`NMR analysis of the crude reaction product. According to
`the same synthetic procedure as that used for 1, 21 was
`converted to the target compound 24 in a three-step
`sequence involving oxidation of the hemiacetal moiety,
`deprotection of the N-Boc group, and reductive N-methyl-
`ation. The enantiomer of 24, ent-24, was also synthesized
`employing ent-2 and 3 in the same manner as that described
`for the synthesis of 24.
`
`2.5. Synthesis of 4-epi-1
`
`in order to disclose the relationships between
`Next,
`muscarinic M2 subtype antagonistic activity and C-4
`stereochemistry in the tricyclic moiety of 1, we examined
`the synthesis of 4-epihimbacine 4-epi-1 by employing 4a-
`carbinol 14b as a starting material. Thus, according to our
`methodology featuring the Julia – Lythgoe coupling reaction
`of the tricyclic sulfone and the chiral piperidinaldehyde that
`was established by the synthesis of 24 as well, we have
`readily succeeded in preparing 4-epi-1 from 14b in eight
`steps.
`
`2.6. Muscarinic M2 subtype binding activity of
`enantiomeric pairs of natural himbacine 1 and ent-1 and
`0S,6
`0R)-diepihimbacine, and 4-epihimbacine
`(2
`
`With enantiomeric pairs of natural himbacine 1 and ent-1
`0
`0
`R)-diepihimbacine 24 and ent-24, and 4-epihim-
`S,6
`and (2
`bacine 4-epi-1 in hand, receptor binding affinity assays
`
`Liquidia's Exhibit 1033
`IPR2020-00770
`Page 5
`
`

`

`9908
`
`M. Takadoi et al. / Tetrahedron 58 (2002) 9903–9923
`
`8). Similarly, acylation of 11 with chloroacetyl chloride
`followed by substitution with morpholine and Jones
`oxidation furnished the morpholin-4-yl acetate derivative
`35 by way of 2-chloroacetate 33 and acetal 34. The
`N-(pyridin-2-yl) carbamate derivative 37 was prepared by
`the reaction of 11 with 2-isocyanatopyridine in situ
`generated from 2-picolinic acid and subsequent oxidation
`with Jones reagent. In a similar fashion, 4b-carbinol 14a
`was transformed to the homologous N-(pyridin-2-yl)
`carbamate derivative 39 (Scheme 9). The (S)-1-Benzyl-
`pyrrolidin-3-yl ether derivative 41 was synthesized using
`commercially available (S)-1-benzylpyrrolidin-3-ol by way
`of O-mesylate 15 derived from 14a. The 1-methylpiperidin-
`3-yl ether derivative 44 was derived from 43 prepared by
`etherification of 15 with readily obtainable (S)-1-(tert-
`butoxycarbonyl)piperidin-3-ol29 followed by reduction of
`the N-Boc group to an N-Me group with lithium aluminum
`hydride. Furthermore, 4b-carbinamine 45 was prepared
`from 14a by the Mitsunobu procedure30 and subsequent
`removal of a phthalide moiety. This reaction was coupled
`with 6-methyl-2-picolinic acid by use of EDCI as a coupling
`reagent, affording the 2-methylpyridine-6-carboxamide 47
`by way of acetal 46.
`
`2.8. Muscarinic binding activity of some novel congeners
`of himbacine 1
`
`Using the thus obtained congeners of 1, receptor binding
`affinity assays against the muscarinic M1 and M2 subtype
`receptors were performed. Unfortunately, as shown in Table
`4, all of the compounds tested exhibited poor M2 receptor
`binding affinity and low selectivity compared to 1. In the
`cases of (E)-olefin compounds (entry 2, 3), 2-methyl-
`pyridine and 1-methylimidazole rings were found to be
`unsuitable for binding muscarinic receptors, probably due to
`the aromaticity and planar structures of these rings. The (Z)-
`olefin 30 appeared to be unrewarding in a manner similar to
`that of the (E)-olefin 28. The congeners bearing the
`bioisosteres of the (E)-olefin structure, e.g., ether (entries
`5, 9, 10), ester (entry 6), carbamate (entries 7, 8), and amide
`(entry 11), also showed weak M1 and M2 receptor binding
`affinity. These observations clearly suggest
`that
`the
`conformations of these congeners might differ greatly
`from that of 1.
`
`Scheme 7. Synthesis of himbacine congeners bearing the natural tricyclic
`moiety (I). (a) nBuLi, 6-methylpyridine-2-carboxaldehyde, DME, 2788C,
`1 h, 100%; (b) 5% Na – Hg, Na2HPO4, MeOH, rt, 2 h, 19%; (c) Jones
`reagent, acetone, rt, 60% (for 26), 13% (for 28), 64% (for 30); (d) nBuLi,
`1-methylimidazole-2-carboxaldehyde, DME, 2788C, 1 h, 62%; (e) 5%
`Na – Hg, Na2HPO4, MeOH, rt, 4 h, 42% (for 27), 20% (for 29).
`
`41, 44, and 47 were designed as representative congeners
`of 1, none of which had hitherto been prepared.
`These congeners were readily prepared from the function-
`alized intermediate for the synthesis of 1 such as 2, 11, and
`14a.
`
`Thus, conversions of 2 to the 2-methylpyridine derivative
`26 and 1-methylimidazole derivatives, 28 and 30 were
`readily obtained by employing a Julia – Lythgoe coupling
`reaction followed by elimination, and then a Jones
`oxidation, both in a similar manner to that described for
`the total synthesis of 1 (Scheme 7). Alkylation of 11 with
`commercially available 2-(chloromethyl)pyridine in the
`presence of NaH, and subsequent Jones oxidation clearly
`provided the 2-pyridylmethyl ether derivative 32 (Scheme
`
`Scheme 8. Synthesis of himbacine congeners bearing the natural tricyclic moiety (II). (a) 2-(chloromethyl)pyridine hydrochloride, NaH, DMF, rt, 14 h, 43%;
`(b) Jones reagent, acetone, rt, 37% (for 32), 55% (for 35), 13% (for 37); (c) chloroacetyl chloride, NaH, DMF, rt, 6 h, 83%; (d) morpholine, 1008C, 5 h, 84%;
`(e) 2-picolinic acid, DPPA, Et3N, toluene, 1008C, 6 h, 64%.
`
`Liquidia's Exhibit 1033
`IPR2020-00770
`Page 6
`
`

`

`M. Takadoi et al. / Tetrahedron 58 (2002) 9903–9923
`
`9909
`
`Scheme 9. Synthesis of himbacine congeners bearing the natural tricyclic moiety (III). (a) 2-picolinic acid, DPPA, Et3N, toluene, 1008C, 7 h, 92%; (b) Jones
`reagent, acetone, rt, 56% (for 39), 64% (for 41), 21% (for 44), 35% (for 47); (c) methanesulfonyl chloride, Et3N, CH2Cl2, 08C to rt, 2.5 h, 100%; (d) (S)-1-
`benzylpyrrolidin-3-ol, NaH, DMF, 808C, 17 h, 8%; (e) (S)-1-(tert-butoxycarbonyl)piperidin-3-ol, NaH, DMF, 808C, 17 h, 38%; (f) lithium aluminum
`hydride, THF, rt, 1 h, then 808C, 1 h, 100%; (g) phthalimide, diethyl azodicarboxylate, Ph3P, THF, 08C to rt, 7 h, 99%; (h) H2NNH2·H2O, EtOH, rt, 4 h, 52%;
`(i) 6-methyl-2-picolinic acid, EDCI, CH2Cl2, rt, 5 h, 80%.
`
`3. Conclusion
`
`In summary, we have succeeded in the highly stereo-
`selective total synthesis of an enantiomeric pair of
`himbacine 1, a potent antagonist of the muscarinic M2
`subtype receptor, by employing an intermolecular Diels –
`Alder reaction of 8 with (S)-9 as a key step. Our explored
`synthetic route was successfully applied to the total
`synthesis of unnatural himbacine ent-1, an enantiomeric
`0
`0
`R)-diepihimbacine 24 and ent-24, and
`S,6
`pair of
`(2
`4-epihimbacine 4-epi-1. Based on the observed muscarinic
`receptor binding affinity assay of these compounds,
`it
`appears that the absolute configuration of 1 plays a pivotal
`role in its activity. Based on the results obtained, selected
`novel congeners of 1 were further prepared by starting with
`
`the intermediates for the total synthesis of 1, and these
`congeners were then subjected to receptor binding affinity
`assay. However, these latter congeners were unfortunately
`also found to exhibit very weak muscarinic M2 subtype
`receptor binding affinity and low selectivity. Although no
`novel congener with a more prominent profile than 1 was
`found, the successful synthesis of various structural types of
`congeners clearly disclosed the convergency and flexibility
`of the explored synthetic route to 1. Our goal to discover a
`novel drug candidate targeting muscarinic M2 subtype
`receptors for the treatment of Alzheimer’s disease still
`remains to be achieved, and studies along this line are
`ongoing in our laboratories.
`
`4. Experimental
`
`Table 4. In vitro binding activity of some novel congeners of himbacine
`
`Entry
`
`Compound
`
`2log Ki
`
`4.1. General
`
`1
`2
`3
`4
`5
`6
`7
`8
`9
`10
`11
`
`1
`26
`28
`30
`32
`35
`37
`39
`41
`44
`47
`
`M1 (cortex)
`
`M2 (brainstem)
`
`7.1
`5.2
`5.2
`,5.1
`!5.1
`!5.1
`!5.1
`!5.1
`5.5
`5.6
`!5.1
`
`7.9
`!6.1
`!6.1
`!6.1
`!6.1
`!6.1
`!6.1
`!6.1
`!5.9
`,5.4
`!6.1
`
`All melting points were determined with a Yamato MP-500
`melting point apparatus, a Yamaco MP-3 micro melting
`point apparatus, or a Yanaco MP-500D micro melting point
`apparatus, and are uncorrected. Measurements of optical
`rotations were carried out using a Horiba SEPA-200
`automatic digital polarimeter, a JASCO DIP-360 automatic
`digital polarimeter, or a P-1020 automatic digital polari-
`meter. Infrared (IR) spectra were recorded with a JASCO
`FT/IR-5300 spectrometer. 1H NMR spectra were measured
`with a JEOL JNM-EX-400 (400 MHz) spectrometer or an
`Avance 500 (500 MHz) spectrometer. 13C NMR spectra
`were taken with a JEOL JNM-EX-400 (100 MHz)
`
`Liquidia's Exhibit 1033
`IPR2020-00770
`Page 7
`
`

`

`9910
`
`M. Takadoi et al. / Tetrahedron 58 (2002) 9903–9923
`
`spectrometer or an Avance 500 (125 MHz) spectrometer.
`The chemical shifts are expressed in parts per million (d
`value) downfield from tetramethylsilane, using tetramethyl-
`
`silane (d¼0) and/or residual solvents such as chloroform
`(d¼7.26) as an internal standard. Splitting patterns are
`
`indicated as s, singlet; d, doublet; t, triplet; q, quartet; m,
`multiplet; br, broad peak. Measurements of mass spectra
`were performed with a JMS-SX102A mass spectrometer.
`Data for elemental analyses are within ^0.3% of the
`theoretical values, and were determined by a Yanaco
`CHN-corder MT-5. Unless otherwise noted, all
`the
`experiments were carried out using anhydrous solvents
`under an atmosphere of dry argon. Throughout
`this
`study, Merck precoated TLC plates (Silica gel 60
`F254, 0.25 mm; Art. 5715) were used for thin layer
`chromatographic (TLC) analysis, and all the spots were
`visualized using UV light followed by coloring with
`phosphomolybdic acid. Wako Gel C-200, Wako Gel
`C-300, Silica gel 60 (0.040 – 0.063 mm, F254; Art. 9385,
`Merck Co., Ltd.), or Chromatorexw NH-DM 1020
`(100 – 200 mesh, Fuji Silysia Chemical, Ltd.) was used as
`an adsorbent for the flash column chromatography.
`
`4.1.1. 3,4,5,6-Tetrahydrobenzo[c]furan (8). 4,5,6,7-Tetra-
`hydroisobenzofuran-5-ol was prepared as a colorless oil
`starting with furfuryl alcohol according to the reported
`103 – 1058C/3 mmHg.
`procedure.14a
`1H NMR
`Bp
`(400 MHz, CDCl3): d 1.56 (d, J¼4.9 Hz, 1H), 1.77 – 1.84
`J¼16.6, 6.0 Hz, 1H), 2.91 (dd, J¼15.7, 4.9 Hz, 1H), 4.10 –
`4.16 (m, 1H), 7.16 – 7.18 (m, 2H). IR (neat): 3360, 2930,

`1640, 1440 cm21. MS (EI) m/z: 138 (M
`), 120, 94 (100).

`HRMS (EI) (m/z): calcd for C8H10O2 (M
`): 138.0681.
`Found, 138.0686.
`
`(m, 1H), 1.90 – 1.97 (m, 1H), 2.49 – 2.63 (m, 2H), 2.77 (dt,
`
`To a solution of 4,5,6,7-tetrahydroisobenzofuran-5-ol
`(34.1 g, 0.25 mol) and triethylamine (68.8 mL, 0.49 mol)
`in CH2Cl2 (400 mL), methanesulfonyl chloride (28.7 mL,
`0.37 mol) was added dropwise at 08C, and the resulting
`mixture was stirred at the same temperature for 1.5 h, then
`gradually warmed to rt. After concentration in vacuo, the
`residue was poured into water (500 mL), and the aqueous
`
`mixture was extracted with diethyl ether (100 mL£3). The
`
`combined organic extracts were washed with brine
`(100 mL), dried over anhydrous Na2SO4, filtered,
`then
`concentrated in vacuo, to give 4,5,6,7-tetrahydroisobenzo-
`furan-5-yl methanesulfonate (53.3 g, 100%) as an oil. This
`material was immediately used for the next reaction without
`further purification. 1H NMR (400 MHz, CDCl3): d 1.99 –
`2.07 (m, 1H), 2.10 – 2.19 (m, 1H), 2.64 – 2.71 (m, 1H), 2.76 –
`2.85 (m, 1H), 2.90 (dd, J¼16.6, 6.4 Hz, 1H), 2.99 – 3.04 (m,
`1H), 3.04 (s, 3H), 5.11 – 5.16 (m, 1H), 7.14 – 7.22 (m, 2H).
`IR (neat): 3650, 2940, 1350, 1170 cm21. MS (EI) m/z: 216

`), 120 (100). HRMS (EI) (m/z): calcd for C8H12O2
`(M

`(M
`): 216.0

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket